These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10967627)

  • 1. Utility evaluations for Markov states of lung cancer for PET-based disease management.
    Papatheofanis FJ
    Q J Nucl Med; 2000 Jun; 44(2):186-90. PubMed ID: 10967627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
    Gambhir SS; Hoh CK; Phelps ME; Madar I; Maddahi J
    J Nucl Med; 1996 Sep; 37(9):1428-36. PubMed ID: 8790186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of non-small-cell lung cancer staging by means of positron emission tomography.
    Albes JM; Lietzenmayer R; Schott U; Schülen E; Wehrmann M; Ziemer G
    Thorac Cardiovasc Surg; 1999 Feb; 47(1):42-7. PubMed ID: 10218620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of non-small-cell lung cancer and application of FDG-PET. A cost modeling approach.
    Verboom P; Herder GJ; Hoekstra OS; Smit EF; van den Bergh JH; van Velthoven PC; Grijseels EW
    Int J Technol Assess Health Care; 2002; 18(3):576-85. PubMed ID: 12391950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease.
    Farrell MA; McAdams HP; Herndon JE; Patz EF
    Radiology; 2000 Jun; 215(3):886-90. PubMed ID: 10831716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA.
    Annema JT; Hoekstra OS; Smit EF; Veseliç M; Versteegh MI; Rabe KF
    Lung Cancer; 2004 Apr; 44(1):53-60. PubMed ID: 15013583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy.
    Gugiatti A; Grimaldi A; Rossetti C; Lucignani G; De Marchis D; Borgonovi E; Fazio F
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):49-61. PubMed ID: 15195004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of positron emission tomography in patients with non-small cell lung cancer.
    Kee F; Erridge S; Bradbury I; Cairns K
    Eur J Radiol; 2010 Jan; 73(1):50-8. PubMed ID: 19084367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
    Makler PT
    J Nucl Med; 1997 Jul; 38(7):1173-4. PubMed ID: 9225819
    [No Abstract]   [Full Text] [Related]  

  • 11. [Detection of unexpected extrathoracic metastases in preoperative staging of non-small-cell bronchial carcinoma (NSCLC) with positron emission tomography (PET)].
    Schmid RA; Hillinger S; Bruchhaus H; Steinert HC; von Schulthess GK; Largiadèr F; Weder W
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1264-7. PubMed ID: 9931854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision-tree sensitivity analysis for cost-effectiveness of whole-body FDG PET in the management of patients with non-small-cell lung carcinoma in Japan.
    Kosuda S; Ichihara K; Watanabe M; Kobayashi H; Kusano S
    Ann Nucl Med; 2002 Jun; 16(4):263-71. PubMed ID: 12126096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Positron emission tomography in the evaluation of intrathoracic lymphatic extension of non-small cell bronchial cancer. A preliminary study of 30 patients].
    Bury T; Corhay JL; Paulus P; Weber T; D'Harcour JB; Limet R; Rigo P; Radermecker MF
    Rev Mal Respir; 1996 Jul; 13(3):281-6. PubMed ID: 8765921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of integrated positron emission tomography/computed tomography and mediastinoscopy in mediastinal staging of non-small cell lung cancer: analysis of 212 patients.
    Iskender I; Kapicibasi HO; Kadioglu SZ; Sevilgen G; Tezel C; Kosar' A; Atasalihi A; Kir A
    Acta Chir Belg; 2012; 112(3):219-25. PubMed ID: 22808763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-minimization analysis of alternative diagnostic approaches in a modeled patient with non-small cell lung cancer and subcarinal lymphadenopathy.
    Harewood GC; Wiersema MJ; Edell ES; Liebow M
    Mayo Clin Proc; 2002 Feb; 77(2):155-64. PubMed ID: 11838649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
    Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of PET using FDG in the diagnosis of lung cancer--first results].
    Rubinstein R; Breuer R; Chisin R
    Harefuah; 2001 Feb; 140(2):100-3, 191. PubMed ID: 11242909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of Pet-18FDG in lung cancer].
    Richter JA; Torre W; Gámez C; Aramendia JM; Crespo A; Nicolás A; Brugarolas A
    Med Clin (Barc); 1999 Nov; 113(15):567-71. PubMed ID: 10605681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in diagnosis of recurrent bronchial carcinoma].
    Ukena D; Hellwig D; Palm I; Rentz K; Leutz M; Hellwig AP; Kirsch CM; Sybrecht GW
    Pneumologie; 2000 Feb; 54(2):49-53. PubMed ID: 10731756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.
    Steinert HC; Hauser M; Allemann F; Engel H; Berthold T; von Schulthess GK; Weder W
    Radiology; 1997 Feb; 202(2):441-6. PubMed ID: 9015071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.